Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify, Tylenol autism cases, Jardiance cases connected to Fournier gangrene, or any other anti-psychotic medication cases. Thank you.
Select Page

Uterine Cancer Cases Related to Hair Straighteners and Relaxers

3 min read

Introduction 

A study from the National Institutes of Health found that in an association of women, who were using hair straightening products, were twice as likely, or more, to develop uterine cancer than women who did not use the hair straightening products.[1]

The study was inconclusive as to whether it was shown that correlation does not necessarily equal causation. The link to cancer so far has not been directly confirmed but it is being tested daily for new information.

Uterine cancer study

Uterine cancer is a particularly rare form of cancer but increases in risk factors as women age. Particularly, the risk factors of uterine cancer increase after menopause.

This research was conducted by 33,000 women taking part in what was known as the “Sister Study,” [2] which is “a large, ongoing study looking for risk factors for breast cancer and other health conditions.” [3]

There was about an 11-year study conducted on a specified group of women who used hair products, including hair dyes, straighteners, and relaxers. According to the American Cancer Society, “women who had reported frequent use of straighteners (more than 4 times in the previous year) were about 2½ times more likely to develop uterine cancer.” [3]

The Michael Brady Lynch Firm

Here at the Michael Brady Lynch firm, we are currently taking on any client with a uterine cancer diagnosis that has been using a hair straightener, dyes, or other products for a period of time greater than 2 years. If you or a loved, one has been injured, please give us a call at 888-585-5970.

Date: November 4, 2022

Author: Brandon Salter

Citations

[1] https://abc7.com/hair-straightening-chemicals-uterine-cancer-hair-products-relaxer/12345976/

[2] https://sisterstudy.niehs.nih.gov/English/about.htm

[3] https://amp.cancer.org/latest-news/study-finds-possible-link-between-hair-straightening-chemicals-and-uterine-cancer.html

 

 

Ormond Beach Abuse Investigation: Riverbend Academy

Ormond Beach Abuse Investigation: Riverbend Academy

Multidistrict litigation (MDL No. 3094) involving GLP-1 receptor agonist medications, such as Ozempic, Wegovy, and Mounjaro, is actively moving forward in the Eastern District of Pennsylvania. Plaintiffs allege that the manufacturers failed to warn users about serious health risks, including gastroparesis, intestinal blockages, and vision loss.

read more
Ozempic, Wegovy & Mounjouro MDL Lawsuit: Latest Updates

Ozempic, Wegovy & Mounjouro MDL Lawsuit: Latest Updates

Multidistrict litigation (MDL No. 3094) involving GLP-1 receptor agonist medications, such as Ozempic, Wegovy, and Mounjaro, is actively moving forward in the Eastern District of Pennsylvania. Plaintiffs allege that the manufacturers failed to warn users about serious health risks, including gastroparesis, intestinal blockages, and vision loss.

read more
PFAS Lawsuit 2025 Update: What You Should Know

PFAS Lawsuit 2025 Update: What You Should Know

The PFAS multidistrict litigation (MDL No. 2873) is moving forward in the District of South Carolina, where over 10,000 cases remain active against major manufacturers like 3M, DuPont, and BASF. While 3M reached a $10 billion settlement in 2023 to resolve water utility claims, no global settlement has been reached for individual personal injury lawsuits.

read more
Fosamax MDL Update 2025: Legal Developments and Case Status

Fosamax MDL Update 2025: Legal Developments and Case Status

Fosamax (alendronate), a widely used osteoporosis drug, remains the subject of multidistrict litigation (MDL) over allegations that it can cause serious bone injuries, including atypical femur fractures and osteonecrosis of the jaw (ONJ). Plaintiffs claim Merck failed to warn users adequately about these risks.

read more
Paragard MDL Updates: What You Should Know

Paragard MDL Updates: What You Should Know

The Paragard IUD remains the subject of a major nationwide lawsuit, with claims alleging the device breaks during removal, leading to serious injuries that the manufacturers, Teva Pharmaceuticals, allegedly failed to adequately warn consumers about. These cases have been centralized in Multidistrict Litigation (MDL) No. 2974, in the Northern District of Georgia.

read more
Understanding the Pre-Litigation Process: What to Do After a Car Accident

Understanding the Pre-Litigation Process: What to Do After a Car Accident

The time period immediately following a car accident is crucial not only for your health, but for protecting your legal rights. Prior to any lawsuits being filed, you enter the pre-litigation phase during which critical steps must be taken. Knowing what to do after an accident can make a major difference in the outcome of your personal injury claim and help preserve your right to compensation.

read more
The Car Accident Negotiation Phase

The Car Accident Negotiation Phase

The negotiation phase after a car accident is often the toughest part of resolving your claim. Insurance companies are skilled at minimizing payouts and may challenge the seriousness of your injuries, the necessity of your medical treatment, or the legitimacy of your lost wages. Getting through this process requires more than patience, it demands strong documentation and experienced legal representation.

read more
×
What Our Clients Are Saying